0001181431-13-011006.txt : 20130220
0001181431-13-011006.hdr.sgml : 20130220
20130220170729
ACCESSION NUMBER: 0001181431-13-011006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130215
FILED AS OF DATE: 20130220
DATE AS OF CHANGE: 20130220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gordon Christopher R
CENTRAL INDEX KEY: 0001432313
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11239
FILM NUMBER: 13627693
MAIL ADDRESS:
STREET 1: C/O BAIN CAPITAL, LLC
STREET 2: JOHN HANCOCK TOWER, 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HCA Holdings, Inc.
CENTRAL INDEX KEY: 0000860730
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
IRS NUMBER: 273865930
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PARK PLZ
CITY: NASHVILLE
STATE: TN
ZIP: 37203
BUSINESS PHONE: 6153449551
MAIL ADDRESS:
STREET 1: ONE PARK PLAZA
CITY: NASHVILLE
STATE: TN
ZIP: 37203
FORMER COMPANY:
FORMER CONFORMED NAME: HCA INC/TN
DATE OF NAME CHANGE: 20010627
FORMER COMPANY:
FORMER CONFORMED NAME: HCA THE HEALTHCARE CO
DATE OF NAME CHANGE: 20010419
FORMER COMPANY:
FORMER CONFORMED NAME: COLUMBIA HCA HEALTHCARE CORP
DATE OF NAME CHANGE: 20000502
4
1
rrd370585.xml
FORM 4
X0306
4
2013-02-15
0
0000860730
HCA Holdings, Inc.
HCA
0001432313
Gordon Christopher R
C/O BAIN CAPITAL PARTNERS, LLC
JOHN HANCOCK TOWER, 200 CLARENDON ST
BOSTON
MA
02116
1
0
1
0
Common Stock, Par Value $0.01
2013-02-15
4
S
0
23576519
35.87
D
50331374
I
See Footnotes
The shares of HCA Holdings, Inc. ("HCA") reported on this Form 4 are held of record by Hercules Holding II, LLC ("Hercules II"). Hercules II is held by a private investor group, including affiliates of Bain Capital Investors, LLC ("BCI"), Kohlberg Kravis & Roberts & Co. LLC and affiliates of HCA founder Dr. Thomas F. Frist, Jr. Affiliates of BCI indirectly own 50,331,374 shares of Common Stock of HCA.
Includes 21,887,938 shares of HCA indirectly sold by Bain Capital Integral Investors, 2006, LLC ("Integral 2006") by virtue of its membership in Hercules II Mr. Gordon is a Managing Director of BCI. Because BCI is the administrative member of Integral 2006, Mr. Gordon may be deemed to beneficially own the 46,773,097 shares of Common Stock of HCA indirectly owned by Integral 2006 by virtue of its membership in Hercules II. Mr. Gordon disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Includes 160,098 shares of HCA indirectly sold by BCIP TCV, LLC ("BCIP TCV") by virtue of its membership in Hercules II. Because BCI is the administrative member of BCIP TCV, Mr. Gordon may be deemed to beneficially own the 337,368 shares of Common Stock of HCA indirectly owned by BCIP TCV by virtue of its membership in Hercules II. Mr. Gordon disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Includes 1,528,483 shares of HCA indirectly sold by Bain Capital Hercules Investors, LLC ("Hercules Investors" together with BCI, Integral 2006 and BCIP TCV, the "Bain Entities") by virtue of its membership in Hercules II. Because BCI is the administrative member of Hercules Investors, Mr. Gordon may be deemed to beneficially own the 3,220,909 shares of Common Stock of HCA indirectly owned by Hercules Investors by virtue of its membership in Hercules II. Mr. Gordon disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
As a result of the relationships described in the foregoing footnotes, Mr. Gordon may be deemed to beneficially own the 174,275,052 shares of Common Stock of HCA held by Hercules II. Mr. Gordon disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
/s/ Christopher Gordon
2013-02-19